Ex-CEO Behind Bars, 10x’s Clinical Ambitions, and Pharma’s AI Gambit

About this episode

The episode discusses the sentencing of a former CEO for fraud, AI investments by drugmakers, and 10x Genomics' expansion into clinical diagnostics.

We kick off the very first episode of 2026 with a major legal development. This week, the former CEO of CytoDyn was sentenced to 30 months in prison, more than a year after being convicted on multiple charges including four counts of securities fraud, two counts of wire fraud, and three counts of insider trading. Also, we examine recent investments in artificial intelligence by several major drugmakers, and where they are hoping the technology can make an impact. Then, the latest from 10x Genomics and its plans to expand into clinical diagnostics through new collaboration. And for some research news, a new study that explores how functional forms of amyloid can create stable memories.   Join GEN editors Corinna Singleman, PhD, Alex Philippidis, Fay Lin, PhD, and Uduak Thomas for a discussion of the latest biotech and biopharma news.  Listed below are links to the GEN stories referenced in this episode of Touching Base :    Ex-CytoDyn CEO Sentenced to 30-Month Prison Term on Fraud, Insider Trading By Alex Philippidis, GEN , January 27, 2026 Pharma Bets Big on AI Platforms with Flurry of New Year Deals By Fay Lin, PhD, GEN Edge , January 22, 2026 JPM: Nvidia…

People in this episode

Hosts: Corinna Singleman, Alex Philippidis, Fay Lin, Uduak Thomas

Topics covered

• legal developments
• biotech news
• pharma AI investments
• clinical diagnostics
• securities fraud
• insider trading
• memory research

Keywords

• CytoDyn
• 10x Genomics
• AI in pharma
• clinical diagnostics
• securities fraud
• insider trading
• memory research

Mentioned in this episode

Organizations: CytoDyn, 10x Genomics, Nvidia, Eli Lilly, Thermo Fisher

More episodes of Touching Base

• A Billion-Dollar Deal, Trial Trouble, Biohub Updates, and Vaccine Research News · June 4, 2026 · 37 min
• AI Scientists, Stock Tumble, Patent Lawsuit, and New Partnerships · May 22, 2026 · 32 min
• Remembering J. Craig Venter, PhD · May 7, 2026 · 44 min
• AI in Oncology Takes Off, Tackling HIV and Liver Disease, Pharma’s Recent Gains · April 23, 2026 · 33 min
• Drugs from a Text Prompt, Wegovy Pill Competition Dampens Lilly’s Surge · April 9, 2026 · 32 min
• Agentic AI, Virtual Cell, LNP Vaccine Boosters, Engineered Organs, and Mergers · March 26, 2026 · 40 min